Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019)
Rockwell Medical's (RMTI) quarterly Restructuring Costs came in at $430000.0 in Q2 2019, down 58.25% YoY from $1.0 million in Q2 2018, and down 58.25% on a QoQ basis from $1.0 million in Q2 2018.
Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019) Analysis & Trends
Rockwell Medical (RMTI) has 2 years of Restructuring Costs data on file, last reported at $430000.0 in Q2 2019.
- Quarterly Restructuring Costs fell 58.25% year-over-year to $430000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2020 was $430000.0 (down 70.55% YoY) and the FY2019 annual result came in at $430000.0, down 58.25% from the prior year.
- Restructuring Costs fell to $430000.0 in Q2 2019, from $1.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.0 million in Q2 2018 to a low of $430000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 430,000.00 |
| Jun 30, 2018 | 1.03 Mn |